Pharmaceutical Executive - PharmExec
Master the Science of Success through aspirational coverage for executive-level decisions, leadership, management, strategy and commercialization professionals.
Why Pharma Marketers Are Embracing Omnichannel Marketing
Jun 30, 2021 — Omnichannel marketing is emerging as the way forward by enhancing engagement across personal, non-personal, and media challenges to meet the integrated needs of providers, patients, and payers. Andrew Burkus. However, adopting an omnichannel approach is not a quick fix. It requires a fundamental shift in how marketers simultaneously orchestrate ...
2022 Pharm Exec Top 50 Companies
Jun 9, 2022 — If 2020 was the “Year of COVID,” as we referred to it in our Pharm Exec 50 feature last year—reflecting on the pandemic’s scope and disruption on all facets of life—then 2021 was surely the year of COVID vaccines and treatments. And, through the prism of our latest rankings of the top 50 global biopharma players based on prescription drug sales, one that will go down in the annals of ...
About Us - PharmExec
Master the Science of Success through aspirational coverage for executive-level decisions, leadership, management, strategy and commercialization professionals.
2024 Pharm Exec Top 50 Companies
Jun 14, 2024 — Dethroning Pfizer at the top of our Pharma 50 is Johnson & Johnson ($53.46 billion in Rx sales), up 6.5% and jumping from third, driven by its “fairly diversified portfolio,” notes Verdin. J&J boasts a pair of treatments among the industry’s top-10 sellers (see chart above), including its longtime immunosuppressant, Stelara, which went ...
Pharmaceutical Executive-03-01-2022 - PharmExec
March 8th 2022. Article Executive Profile. After helping lead Novo Nordisk on a transformational journey from a troubled 2016 to double-digit growth in 2021, Doug Langa, Executive Vice President, Head of North America Operations and President of Novo Nordisk, Inc., is calling on his experience of taking the less conventional and sometimes ...
Teva Advances Generics Consolidation with Ivax Purchase
Aug 1, 2005 — Teva's recent purchase of Ivax has analysts wondering where the push for bigger and more global generic manufacturing companies will take the industry. Continuing its efforts to stay on top of the generic pharmaceutical industry, Teva Pharmaceutical Industries Ltd. purchased Ivax Corp. for $7.4 billion, July 25.
FDA Clears Neuralace Medical’s Noninvasive Axon Therapy
Jan 12, 2024 — The FDA has granted clearance to Neuralace Medical’s Axon Therapy, which is a noninvasive treatment for chronic pain related to nerve damage caused by diabetes, known as painful diabetic neuropathy (PDN). 1 Axon Therapy utilizes a pioneering approach of magnetic peripheral nerve stimulation (mPNS) to deliver a quick, painless, and non-invasive treatment.
Amgen's Novel Weight Loss Drug Shows Potential for Longer …
Feb 6, 2024 — Amgen’s novel weight loss drug candidate maridebart cafraglutide (MariTide) showed significant promise in a Phase I trial (NCT04478708), with data suggesting longer lasting and durable reductions in body weight compared with the popular glucagon-like peptide (GLP)-1 agonists currently on the market—Novo Nordisk’s Wegovy (semaglutide) and Eli …
Survey Reveals Best Companies to Work for in Medical Sales
December 1, 2020. Article. 10th Annual Best Places to Work in Medical Sales survey polled over 2,000 professionals. A new survey by MedReps, a career site for medical sales representatives, has revealed that Syneos Health, Teleflex, and Acella & Avion Pharmaceuticals as the overall best medical sales companies to work for in 2021.